The working group discussed the vulnerability risks of critical medicines supply chains; lessons learned from pilot exercise; prioritizing structural vulnerabilities; and effective mitigation measures. The focus of the Critical Medicines Alliance meeting was on identifying and prioritizing key structural supply chain vulnerabilities with an EU dimension for potential EU-level intervention.